# Cancer Center Support Grant

> **NIH NIH P30** · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · 2020 · $150,000

## Abstract

Project Summary
Since the last competitive review of this Cancer Center Support Grant (CCSG) in 2012, the NCI-designated
Perlmutter Cancer Center (PCC), previously NYU Cancer Institute, has weathered the devastation of
Superstorm Sandy and emerged into a period of profound transformation and expansion. Propelled by a
transformative gift from Laurie and Isaac Perlmutter, renewed and enhanced institutional support from the NYU
Langone Health system (NYULH) and a new Director, we have overhauled our leadership team, expanded our
clinical and research facilities, and developed a new strategic vision and began implementing a new Strategic
Plan. Guided by this plan, our Scientific Programs and Shared Resources have been restructured, and we
embarked on a major recruitment campaign that has yielded 12 additional new leadership and/or senior faculty
recruits, 15 other new cancer center faculty recruits, and 68 new members overall. Under revised, more
stringent criteria, membership has been streamlined to 180 full members and 56 associate members. Members
carry out research as part of 5 Scientific Programs, Cancer Genome Dynamics, Cancer Cell Biology, Tumor
Immunology, Melanoma, or Epidemiology and Cancer Control, assisted by 10 Shared Resources and 2
Developing Shared Resources. Our clinical trials office has been reorganized and substantially expanded
under new leadership and a new Phase I unit has opened. Subsequently, trial availability, quality, and accrual
have increased, while the time to trial opening has been markedly reduced. In line with our increased
geographic scope and patient population, we have redefined and enlarged our catchment area. Aided by the
creation of a new Department of Population Health at NYU Langone School of Medicine and the College of
Global Public Health at the NYU main campus, our Population Sciences research has increased in breadth
and quality. Most importantly, our laboratory scientists have made paradigm-shifting discoveries, our clinicians
have led multiple practice-changing trials, and our population scientists have yielded new insights into the
causes of cancer and how to control the disease, contributed to major public health policy changes and
initiatives, and established new community outreach programs that address the specific cancer burdens and
health disparities in our catchment area. Although PCC is located in a city with four other NCI-designated
cancer centers, our catchment area differs substantially from the others: we are the major provider to lower
Manhattan, and have expanded into Brooklyn, the largest and fastest growing borough in New York City, as
well as to Queens and Long Island.

## Key facts

- **NIH application ID:** 10245455
- **Project number:** 3P30CA016087-39S3
- **Recipient organization:** NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- **Principal Investigator:** BENJAMIN G. NEEL
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $150,000
- **Award type:** 3
- **Project period:** 1997-12-01 → 2024-02-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10245455

## Citation

> US National Institutes of Health, RePORTER application 10245455, Cancer Center Support Grant (3P30CA016087-39S3). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10245455. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
